What's new

Human medicines European public assessment report (EPAR): Karvezide, irbesartan,hydrochlorothiazide, Date of authorisation: 16/10/1998, Revision: 50, Status: Authorised

Human medicines European public assessment report (EPAR): Karvezide, irbesartan,hydrochlorothiazide, Date of authorisation: 16/10/1998, Revision: 50, Status: Authorised

Feb 11, 2025 - 17:06
 0
Human medicines European public assessment report (EPAR): Karvezide, irbesartan,hydrochlorothiazide, Date of authorisation: 16/10/1998, Revision: 50, Status: Authorised
Human medicines European public assessment report (EPAR): Karvezide, irbesartan,hydrochlorothiazide, Date of authorisation: 16/10/1998, Revision: 50, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): CoAprovel, irbesartan,...

Next Article

Microsoft and EDPR sign VPPAs for 389MW of US solar capacity

Related Posts

EMEA-002727-PIP02-23

EMEA-002727-PIP02-23

Mar 4, 2025  0

Human medicines European public assessment report (EPAR): Rivastigmine 1 A Pharma, rivastigmine, Date of authorisation: 11/12/2009, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 4, 2025  0

Fees payable to the European Medicines Agency: Fees, charges and remuneration for assessment procedures and services relating to veterinary medicinal products

Fees payable to the European Medicines Agency: Fees, ch...

Apr 15, 2025  0